Cancer News and Research

Latest Cancer News and Research

State highlights: Medi-Cal rate cuts loom; Latin American docs help meet need

In an office decorated with Chinese art and diagrams of body parts, Dr. George Ma cares for more than 4,000 patients. Nearly three-quarters are covered by Medi-Cal, the state's public insurance program for low-income Californians, and Ma said he receives $10 a month to treat most of them (Gorman and York, 6/10).

12 Jun 2013

Asian cinema represents next major battleground for anti-smoking, anti-cancer groups

A University of Adelaide expert says that while the war against smoking in Hollywood movies has been largely won, Asian cinema represents the next major battleground for anti-smoking and anti-cancer groups.

12 Jun 2013

New SPECT and MR imaging systems unveiled at SNMMI's 2013 Annual Meeting

The Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meetingmarks the unveiling of the successful application of a new preclinical hybrid molecular imaging system-single photon emission tomography and magnetic resonance -which has exceptional molecular imaging capabilities in terms of potential preclinical and clinical applications, technological advancement at a lower cost, and reduction of patient exposure to ionizing radiation.

12 Jun 2013

Anti-nicotine vaccination can increase accumulation of nicotine in the brain, say neuroscientists

Researchers have yet again been sent back to the drawing board in the development of the much-sought-after vaccination for smokers, which would hypothetically inhibit the action of nicotine and its pleasure-producing chemical response in the brain.

12 Jun 2013

Integrating exercise into cancer follow-up care can improve recovery, say Miriam Hospital researchers

Telephone-based counseling, when combined with physician advice, can help breast cancer survivors become more physically active, which can improve quality of life and lessen the side effects of cancer treatment, according to new research from The Miriam Hospital.

12 Jun 2013

TSRI scientists identify key triggers of cancer-blocking mechanism in cells

Scientists at The Scripps Research Institute have identified key triggers of an important cancer-blocking mechanism in cells.

12 Jun 2013

PSMA enzyme could become hallmark of new generation of biomarkers for prostate cancer treatment

No matter where they have hidden, metastatic prostate cancer cells still express some of the same signaling as normal prostate cells; in some cases even more so, as with the PSMA enzyme. Harnessing this enzyme could mean the beginning of a new platform for prostate cancer detection, staging, treatment and post-treatment monitoring, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.

12 Jun 2013

PET and MR imaging can improve quality of life and survival for advanced breast cancer patients

For patients with advanced breast cancer, positron emission tomography and magnetic resonance imaging can improve quality of life and survival by providing physicians with information on the effectiveness of chemotherapy prior to surgery, say researchers presenting at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.

12 Jun 2013

Countrywide study in Germany deems PRRT as life-prolonging treatment for patients with NETs

Peptide-receptor radionuclide therapy has been a subject of growing research on neuroendocrine tumors, which take up residence in a variety of organs replete with nerve cells that respond to hormone signaling.

12 Jun 2013

Research could lead to new ways to combat chlamydia

A protein secreted by the chlamydia bug has a very unusual structure, according to scientists in the School of Medicine at The University of Texas Health Science Center San Antonio. The discovery of the protein's shape could lead to novel strategies for diagnosing and treating chlamydia, a sexually transmitted disease that infects an estimated 2.8 million people in the U.S. each year.

12 Jun 2013

Studies demonstrate that combined therapy could destroy drug-resistant cells within melanoma tumor

Advanced metastatic melanoma is a disease that has proven difficult to eradicate. Despite the success of melanoma-targeting drugs, tumors inevitably become drug resistant and return, more aggressive than before. In the current issue of the journal Cancer Cell, however, researchers at The Wistar Institute describe how they increase the effectiveness of anti-melanoma drugs by combining anticancer therapies with diabetes drugs.

12 Jun 2013

New weapon in the fight against childhood brain cancer emerges

A relatively new weapon in the fight against childhood brain cancer has emerged that improves upon standard magnetic resonance imaging by providing information about tumor metabolism and extent of cancer in children diagnosed with glioma, a growth caused by the abnormal division of glial cells in the brain, say researchers at the Society of Nuclear Medicine and Molecular Imaging's 2013 Annual Meeting.

11 Jun 2013

ARIAD Pharmaceuticals initiates ponatinib Phase 2 trial in adult patients with metastatic GIST

ARIAD Pharmaceuticals, Inc. today announced the initiation of the Phase 2 trial of Iclusig (ponatinib) in adult patients with metastatic and/or unresectable gastrointestinal stromal tumors.

11 Jun 2013

Prostate cancer and DNA: an interview with Dr. Jianfeng Xu, Wake Forest School of Medicine

Prostate cancer development is associated with both inherited and acquired genetic alterations. More than 70 inherited genetic variants have been consistently identified in human DNA that may contribute to susceptibility or risk of prostate cancer.

11 Jun 2013

Surgical oncologist receives grant further explore tumor suppressor function of mutated gene

Darren Carpizo, MD, PhD, a surgical oncologist in the Liver Cancer and Bile Duct Cancer Care Program at the Cancer Institute of New Jersey, has been awarded a $200,000 grant from the Sidney Kimmel Foundation for Cancer Research to further explore the effects of a compound identified in his laboratory found to restore tumor suppressor function of a mutated gene in cancer cells.

11 Jun 2013

UCLA study shows progesterone can be used as therapy for endometrial cancer

Progesterone, a female hormone that can be used as a therapy for endometrial cancer, eliminates tumor cells indirectly by binding to its receptor in stromal or connective tissue cells residing in the tumor microenvironment, according to a study from the G.O. Discovery Lab team and collaborators at UCLA.

11 Jun 2013

Study shows iron-uptake receptor plays a role in HCV infection

Hepatitis C virus (HCV) infects more than 170 million people worldwide. Approximately 80 percent of infections lead to chronic illness including fibrosis, cirrhosis, cancer and also hepatic iron overload.

11 Jun 2013

Combination of cell-killing radioactive particle and antibody is safe for treating cancers

An experimental treatment that combines a cell-killing radioactive particle with an antibody that homes in on cancer cells is safe in the treatment of cancers spreading through patients' abdomens, according to data from a first-in-human study presented today at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver.

11 Jun 2013

Rapamycin improves cardiac function in mice suffering from age-related heart disease

Elderly mice suffering from age-related heart disease saw a significant improvement in cardiac function after being treated with the FDA-approved drug rapamycin for just three months.

11 Jun 2013

Going viral with public health messages

Kaiser Health News reports on how one doctor is using YouTube to communicate public health messages while The Washington Post reports on how a data event leads to consideration of health care cost solutions.

11 Jun 2013

Cancer News and Research

Latest Cancer News and Research

State highlights: Medi-Cal rate cuts loom; Latin American docs help meet need

Asian cinema represents next major battleground for anti-smoking, anti-cancer groups

New SPECT and MR imaging systems unveiled at SNMMI's 2013 Annual Meeting

Anti-nicotine vaccination can increase accumulation of nicotine in the brain, say neuroscientists

Integrating exercise into cancer follow-up care can improve recovery, say Miriam Hospital researchers

TSRI scientists identify key triggers of cancer-blocking mechanism in cells

PSMA enzyme could become hallmark of new generation of biomarkers for prostate cancer treatment

PET and MR imaging can improve quality of life and survival for advanced breast cancer patients

Countrywide study in Germany deems PRRT as life-prolonging treatment for patients with NETs

Research could lead to new ways to combat chlamydia

Studies demonstrate that combined therapy could destroy drug-resistant cells within melanoma tumor

New weapon in the fight against childhood brain cancer emerges

ARIAD Pharmaceuticals initiates ponatinib Phase 2 trial in adult patients with metastatic GIST

Prostate cancer and DNA: an interview with Dr. Jianfeng Xu, Wake Forest School of Medicine

Surgical oncologist receives grant further explore tumor suppressor function of mutated gene

UCLA study shows progesterone can be used as therapy for endometrial cancer

Study shows iron-uptake receptor plays a role in HCV infection

Combination of cell-killing radioactive particle and antibody is safe for treating cancers

Rapamycin improves cardiac function in mice suffering from age-related heart disease

Going viral with public health messages

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in